Critical Materials
PrivateRight company, real super-cycle, wrong entry — a world-class tungsten crown jewel buried inside a low-margin battery-materials SOE, already +222% in 52 weeks at ~20x forward earnings on peak tungsten prices; own the thesis, watch the vehicle.
Research
The verdict
Right company, real super-cycle, wrong entry — a world-class tungsten crown jewel buried inside a low-margin battery-materials SOE, already +222% in 52 weeks at ~20x forward earnings on peak tungsten prices; own the thesis, watch the vehicle.
Xiamen Tungsten is not one company; it is three commodity-processing businesses stapled together under a Fujian state holding company, and reading it as a "tungsten stock" is the first mistake most people make. FY2025 revenue split almost evenly between the two big legs, with rare earth a distant third:
| Segment | FY2025 revenue | % of total | What it actually is |
|---|---|---|---|
| Battery / Energy New Materials | CNY 19.81bn (~$2.76bn) | 42.83% | Cathode materials via 50%-owned listed sub XTC New Energy (688778.SS) — world #1 in lithium cobalt oxide (LCO), plus NCM ternary, LFP, sodium-ion, hydrogen-storage alloys |
| Tungsten & Molybdenum (non-ferrous) | CNY 19.63bn (~$2.73bn) | 42.43% | Full tungsten chain: concentrate → APT → tungsten/carbide powder → cemented carbide → ultra-fine tungsten wire (PV wafer-cutting). Plus molybdenum products |
| Rare Earth | CNY 6.0bn (~$0.84bn) | 12.97% | Heavy-REE (dysprosium/terbium) mining, separation and magnet alloys in Fujian — now being folded into China Rare Earth Group JVs |
The critical insight the revenue split hides: tungsten & molybdenum is ~42% of revenue but the dominant share of profit. The non-ferrous business booked FY2025 total profit of CNY 1.451bn on a 28.38% gross margin (+1.87pp YoY) — that single segment is ~63% of the group's CNY 2.309bn attributable net profit. The battery leg, despite carrying ~43% of revenue, throws off razor-thin margins (sub-sidiary XTC earned just CNY 494m net in 2024 on CNY 13.3bn revenue — a ~3.7% net margin — and Xiamen consolidates only ~half of it). Tungsten is the crown jewel; battery materials is the revenue diluent that depresses blended margin and ties the P&L to the lithium/cobalt price cycle.
Business model per leg:
Map the tungsten chain end-to-end — names, not categories (this lens fails if it stays generic):
Upstream (feedstock — the pinch point):
Midstream (Xiamen's core — smelting/processing): concentrate → APT (ammonium paratungstate) → tungsten oxide → tungsten powder / tungsten carbide powder → cemented carbide (via subsidiary Xiamen Golden Egret / "Jinlu" Special Alloy) and ultra-fine tungsten wire. This is where Xiamen has global scale and the ~68% internal-consumption integration.
Downstream (customers / end markets):
Battery chain (separate): lithium (Ganfeng/Tianqi-tier), cobalt (CMOC/Huayou), nickel → XTC precursors → cathode → cell makers (Sunwoda partnership on solid-state disclosed Dec 2024; CATL/ATL-tier 3C buyers).
Chokepoint verdict: the single-source dependency that matters is Xiamen's own concentrate feed. The CMOC/Luoyang Yulu suspension (below) proves the group is processing-long, feedstock-short in a super-cycle where feed is the scarce thing — a genuine vulnerability the revenue-scale story obscures.
Xiamen's moat is policy + scale + integration, in that order — and the ranking matters because the first is not really Xiamen's own moat.
Bargaining power: strong over export buyers (licence scarcity), weak-to-neutral over feedstock (quota + JV partners like CMOC can and did squeeze), and weak in battery (price-takers on lithium/cobalt). Net: the moat is strongest exactly where policy is doing the work, which is the tell that this is a policy trade wearing a company's clothes.
FY2025 by segment (revenue):
| Segment | FY2025 rev (CNY) | % total | Segment profit signal | Trend |
|---|---|---|---|---|
| Battery / energy materials | 19.81bn | 42.83% | Thin (XTC ~3.7% net margin '24) | Revenue recovering off lithium-crash trough; margin structurally low |
| Tungsten & molybdenum | 19.63bn | 42.43% | Total profit 1.451bn (+3.69%), GM 28.38% (+1.87pp) | Accelerating hard into 2026 on tungsten price |
| Rare earth | 6.0bn | 12.97% | Modest; being consolidated | Strategically rising (HREE export controls), operationally being ceded to CREG |
Group trajectory:
(Conflict flagged & resolved: one aggregator returned "2024 revenue CNY 53.59bn" — contradicted by three independent sources and the company's own "−10.48%/+8.60%" release. The CNY 35.271bn / 1.740bn figures are used; the 53.59bn figure is discarded as garbled.)
The latest print is explosive and cyclical: Q1 2026 revenue CNY 15.74bn, +86.99% YoY; attributable net profit CNY 1.11bn, +189.14% YoY. Drivers:
Balance-sheet / quality flags to watch: with commodity prices spiking, working capital is the thing to interrogate — inventory and receivables can balloon faster than cash during a price melt-up, and cost pass-through can reverse violently. Specific WC lines are n/a (no filing on the shelf; Chinese interim disclosure is thin in English). Market reaction: the stock made an all-time high of CNY 81.56 on 4 Mar 2026 (a short-term double) and has since pulled back ~20% to CNY 65.11 — the market is treating peak-cycle prints with appropriate suspicion.
Limitation, stated plainly: Xiamen is an A-share SOE and does not hold English-language earnings calls; there are no transcripts on the shelf or the public web to run sentiment on. Proxy read from management commentary in results releases and Chinese filings:
The tonal arc is real but commodity-driven, not strategy-driven — management's confidence tracks the APT price, which is the honest way to read it. The thing they stopped saying is the 2023-vintage anxiety about battery-materials margins; the thing they started saying is raw-material security — which the CMOC dispute then immediately tested.
Xiamen sits awkwardly between two comp sets — Chinese SOE tungsten/materials names, and the Western "supply-security premium" rare-earth stocks.
| Company | Ticker | Mkt cap | P/E | EV/EBITDA | P/S | Note |
|---|---|---|---|---|---|---|
| Xiamen Tungsten | 600549.SS | 33.4 ttm / 20.7 fwd | 17.0 | ~2.2x | ROE 16.85%; div ~0.9% | |
| Almonty Industries | AII.TO | ~$5.06bn | n/a | n/a | n/a | Ex-China pure-play tungsten (Sangdong, Korea) — the cleanest Western beneficiary of the same squeeze |
| China Tungsten & Hightech | 000657.SZ | n/a | n/a | n/a | n/a | Minmetals carbide champion; Q1 net +264% — closest domestic tungsten peer |
| China Northern Rare Earth | 600111.SS | n/a | n/a | n/a | n/a | World's largest REE producer; ~7.15% of REMX ETF |
| MP Materials | MP | ~$12.36bn | FY25 loss; FY26 EPS est $0.92 | n/a | fwd 20.5x | Western REE supply-security premium |
| Lynas Rare Earths | LYC.AX | ~$12bn | FY26 EPS est $0.18 | n/a | fwd 19.4x | Ex-China REE |
Read: on sales, Xiamen at ~2.2x is an order of magnitude cheaper than MP/Lynas at ~20x — but that gap is correct, not an opportunity: MP/Lynas are near-breakeven story stocks priced on Western supply-security scarcity, while Xiamen is a profitable, taxed, state-directed Chinese cyclical. On its own history, Xiamen at ~20x forward earnings and 17x EV/EBITDA on peak-cycle tungsten is not cheap — that is a full multiple on top-of-cycle earnings, which is how cyclicals set bull traps. The most useful comp for an actionable trade is Almonty (AII.TO): same tungsten tailwind, no China governance/ownership friction, and (per North-Star coverage rules favouring being early in ex-China frontier supply) a cleaner vehicle for MenFem's audience.
What actually moves 600549:
Pattern: the market reacts to the tungsten price and Chinese state policy far more than to any company-specific execution. This is a commodity-and-policy beta, not an operational compounder. The single most important variable for the next 12 months is the APT/concentrate price, followed by export-quota policy — neither of which management controls.
Ownership — this is a state-controlled enterprise, full stop. Controlling shareholder is Fujian Metallurgical (Holding) Co., Ltd at ~31% (30.69% Dec-2024, ~31% by Feb-2025), which has been increasing its stake (bought +1.66m shares) — a modestly positive alignment signal. China Minmetals holds ~7.68%. Ultimate control traces to SASAC (Fujian provincial + central via Minmetals). Governance implication: exports and asset structure serve Beijing's industrial strategy first, minority shareholders second — the rare-earth consolidation (Lens 13) is the proof.
Leadership: long-tenured SOE management (chairman/president in seat since ~2015; chairman comp ~CNY 1.5m ≈ $210k in 2024 — typical low SOE pay, meaning near-zero equity-style skin in the game for operators; alignment runs through the state parent, not management shareholding). (Exact current names return conflicting web values — treated as n/a — not reliably sourced rather than asserted.)
Capital allocation: disciplined-to-conservative. Retained the high-margin tungsten core while listing (not selling) the battery arm — XTC's 2021 STAR-Market IPO crystallised value while keeping 50% control and consolidation. Dividend is token (~0.9% yield, CNY 0.58) — capital is retained for integration/capex, appropriate for a cyclical but unfriendly to income holders. ROE 16.85% is respectable for a materials SOE. Red flags: related-party complexity (Fujian-state web, multiple listed subs 600549/688778), and the structural subordination of minority interests to state consolidation goals.
Analytical caution items (no filing on the shelf — all ``/inference; specific line items n/a):
Regulatory findings (required sub-section).
regulatory/regulatory-findings.md records 0 findings — Xiamen has no CIK and no SEC jurisdiction (not a US filer). No LR/AAER possible.Built bottom-up off FY2025 actuals + the Q1'26 run-rate. Shares outstanding ~1.59bn; FY2025 attributable NP CNY 2.309bn → FY2025 EPS ≈ CNY 1.45 ``. (Per the watchlist rule and this run's constraints, no forecast.ts forecast is logged.)
| Scenario | FY2026E net profit | FY2026E EPS | Key assumptions |
|---|---|---|---|
| Bull | ~CNY 4.4bn | ~CNY 2.77 `` | Tungsten holds near peak all year; Q1'26's CNY 1.11bn run-rate broadly sustained; PV wire volume strong; battery recovers. (Q1 ×4 = CNY 4.44bn, but Q1 was front-loaded, so treat as the ceiling) |
| Base | ~CNY 3.8–4.0bn | ~CNY 2.45 `` | Tungsten price elevated but eases off H1 peak; tungsten-moly profit roughly doubles vs 2025's CNY 1.451bn; battery flat-to-up; rare earth modest. ≈ +65–75% NP growth |
| Bear | ~CNY 3.0bn | ~CNY 1.89 `` | Tungsten corrects in H2 2026 (cyclical); pass-through reverses; battery margins stay thin; CMOC-style feed disruptions clip volume |
FY2027–28 hinge almost entirely on whether tungsten holds — base case assumes normalisation off the 2026 peak, so EPS likely plateaus then modestly declines from a 2026 peak rather than compounding (the cyclical's tell): FY2027E EPS ~CNY 2.1–2.4, FY2028E ~CNY 1.9–2.3 ``. At CNY 65.11, the stock is ~27x FY2025 EPS and ~20x base FY2026E EPS — i.e. paying a full multiple for peak-cycle earnings. That is the crux of the caution.
Bull case. Xiamen is the single best-positioned Chinese vehicle for a genuine, policy-manufactured tungsten super-cycle: on the inside of both the mining quota and the export licence, world-scale integration, ~68% internal carbide consumption capturing the spread, and a real PV-tungsten-wire share-gain product. Q1'26 net +189% is not noise — it's cost pass-through on a strategic metal the West cannot easily source (China tungsten exports to Japan hit zero). Add optionality: a 49% economic stake in a consolidated national heavy-REE champion (dysprosium/terbium — the most export-strategic REEs) and a #1 global LCO franchise recovering off trough. If tungsten stays scarce (military + AI-toolchain + PV demand vs −6.5% quota, −40% exports), FY2026 earnings re-rate the whole group.
Bear case (2–3 permanent-impairment risks).
Pre-mortem (18 months out, thesis broke): tungsten corrected 30% off the 2026 peak as high prices triggered demand destruction (wafer cutters thrift tungsten wire; export buyers designed around Chinese supply) and quota relaxed; battery margins stayed thin; the group printed a lower 2027 EPS off a 2026 peak, and the 20x multiple compressed to 12x — a ~40% drawdown despite a "structurally intact" story. Contrarian view the market is refusing to see: the market is trading 600549 as a secular winner when it is a policy-beta cyclical whose best segment it doesn't fully control and whose feed it can't guarantee.
Dismantling the bull case: The bull thesis is entirely a bet on the tungsten price and on Beijing keeping the export screws tight — neither is a company moat. Structural break points:
Research Trail
Covered in the Knowledge Base
Critical Materials
Operationally the best growth story in large-cap mining — ~10%/yr copper+gold volume compounding, ~25% ROE, 60% mineral gross margins — priced two-to-three turns below Western copper peers on a discount that is structural, not temporary (UFLPA listing, China-SOE governance, hardest-jurisdiction asset base). Bullish the metal, skeptical of the re-rating.
Best-in-class precious-metals streamer — ~78% cash margins, fortress balance sheet, ~50% production growth to 2030 and the largest streaming deal ever (BHP Antamina, $4.3B) locked in — but priced as such (sector-high ~1.97x P/NAV, ~27x earnings). At ~$111 it is a de-risked, leveraged long-gold/silver bet with acute Salobo concentration, not a value entry. Direction hinges on the metal price and the Antamina ramp, not the model.